With billions of dollars on the line, Gov. Greg Abbott is back in Washington, D.C. for the second straight week.
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...